DMG-PEG2000-NH2: NH2-PEG Derivative for Lipid Nanoparticles

Executive Summary: DMG-PEG2000-NH2 is a primary amine-functionalized polyethylene glycol (PEG) derivative designed for efficient amide bond formation with carboxyl-containing biomolecules (source: product_spec). It is widely used as a linker in lipid nanoparticle (LNP) and liposomal drug delivery systems, improving both stability and solubility of encapsulated therapeutic agents such as siRNA (source: workflow_recommendation). The compound exhibits high purity (>90%) and excellent solubility in DMSO, ethanol, and water (source: product_spec). Storage at -20°C is essential to maintain reagent stability (source: product_spec). APExBIO supplies DMG-PEG2000-NH2 as a research-only reagent for advanced biomedical applications.

Biological Rationale

PEGylation, the covalent attachment of polyethylene glycol chains to biomolecules, is a well-established strategy for enhancing pharmacokinetics, solubility, and biocompatibility in drug delivery (DOI). DMG-PEG2000-NH2 specifically features a primary amine group at one terminus of a 2000 Da PEG chain, enabling site-selective conjugation to carboxylated drugs, peptides, or proteins via amide bond formation. This functionalization is particularly valuable for constructing stable, stealth lipid nanoparticles (LNPs) or liposomes for encapsulating payloads prone to degradation or immune clearance, such as siRNA (workflow_recommendation).

Mechanism of Action of DMG-PEG2000-NH2

DMG-PEG2000-NH2 acts as a bifunctional linker. The DMG (dimyristoylglycerol) lipid anchor integrates into the hydrophobic lipid bilayer, while the PEG2000-NH2 moiety extends into the aqueous phase (workflow_recommendation). The primary amine (-NH2) undergoes amide coupling with carboxyl groups on therapeutic cargo or targeting ligands, typically using carbodiimide chemistry (e.g., EDC/NHS activation) (DOI). This results in a stable covalent bond, facilitating efficient bioconjugation for LNP or liposomal drug delivery linker applications. The PEG spacer imparts hydrophilicity and steric hindrance, reducing non-specific protein adsorption and improving circulation half-life.

Evidence & Benchmarks

• DMG-PEG2000-NH2 exhibits a molecular weight of 2528 Da, supporting precise stoichiometric calculations in nanoparticle assembly (product_spec).
• Solubility benchmarks: ≥51.6 mg/mL in DMSO, ≥52 mg/mL in ethanol, and ≥25.3 mg/mL in water, enabling flexible formulation approaches (product_spec).
• Pegylated lipids such as DMG-PEG derivatives are proven to reduce opsonization and prolong circulation times of nanoparticles in vivo (DOI).
• Amide bond formation between PEG-NH2 and activated carboxyls is robust and widely used for conjugating peptides, proteins, and small molecules (workflow_recommendation).
• High purity (>90%) ensures reproducible performance in research workflows (product_spec).

This article extends previous coverage in "DMG-PEG2000-NH2: Enabling Efficient Liposomal Drug Delivery" by detailing quantitative solubility and purity metrics under defined storage conditions, clarifying practical boundaries for reproducible nanoparticle preparation.

Applications, Limits & Misconceptions

DMG-PEG2000-NH2 is primarily used in constructing lipid-based drug delivery platforms, including liposomes and LNPs, for encapsulating and delivering nucleic acids (such as siRNA), proteins, or small molecule drugs (workflow_recommendation). Its primary amine group allows for site-selective conjugation, minimizing random cross-linking. In LNP formulation, it serves as a 'stealth' component, reducing immune clearance. However, solutions of DMG-PEG2000-NH2 are not recommended for long-term storage and must be freshly prepared (product_spec).

Common Pitfalls or Misconceptions

• Assuming all PEG derivatives provide identical pharmacokinetics—chain length, end-group, and lipid anchor significantly affect circulation and biodistribution (DOI).
• Using DMG-PEG2000-NH2 solutions stored for prolonged periods reduces functional amine availability (source: product_spec).
• Employing DMG-PEG2000-NH2 for diagnostic or clinical use is not permitted; it is strictly for research applications (source: product_spec).
• Confusing DMG-PEG2000-NH2 with maleimide-terminated or other functionalized PEGs—amide coupling is specific to primary amines and carboxyls.
• Neglecting to control pH during conjugation reactions can lead to hydrolysis or reduced coupling efficiency (workflow_recommendation).

This analysis clarifies and updates the mechanistic discussion in "DMG-PEG2000-NH2: Revolutionizing Lipid Nanoparticle Translation" by providing explicit pitfalls and boundaries for laboratory use.

Workflow Integration & Parameters

For optimal results, researchers are advised to consult both manufacturer recommendations and the latest peer-reviewed protocols. Below are structured parameters to guide experimental design.

Protocol Parameters

• Solubility assay | ≥51.6 mg/mL (DMSO); ≥52 mg/mL (ethanol); ≥25.3 mg/mL (water) | Solubility screening for LNP and liposome prep | Ensures compatibility with most organic and aqueous formulation protocols | product_spec
• Storage | -20°C (solid) | Preserves functional group integrity for at least 6 months | Prevents hydrolysis and amine degradation | product_spec
• Amide bond coupling | pH 7.0–7.5 (buffered), EDC/NHS activation, 2–4 hours at room temperature | Efficient conjugation to carboxylated biomolecules | Maintains selective reactivity, avoids side reactions | workflow_recommendation
• Concentration in LNP formulations | 0.5–5 mol% relative to total lipid | LNP, liposome, or micelle assembly | Balances stealth effect and membrane stability | workflow_recommendation
• Purity check | ≥90% by HPLC | QC for reproducible delivery performance | Minimizes batch-to-batch variation | product_spec

This section updates the troubleshooting focus found in "DMG-PEG2000-NH2: Advanced NH2-PEG Derivative in LNP Workflows" by providing explicit, literature-backed parameter values.

Conclusion & Outlook

DMG-PEG2000-NH2, as supplied by APExBIO, is a high-purity, amine-functionalized PEG-lipid designed for advanced research in lipid nanoparticle and liposomal drug delivery. Its robust solubility, biocompatibility, and reliable amide bond formation make it a preferred reagent for siRNA encapsulation and beyond (product_spec). Recent advances in antimycobacterial drug development, as exemplified by optimized sulfonamide derivatives (DOI), further highlight the importance of modular, versatile linker chemistries in translational research. Ongoing improvements in LNP design and functionalization are expected to broaden the scope and impact of PEGylated linkers in precision medicine.